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Electrical stimulation of baroreceptor afferents was used in the 1960’s in several species, including human beings, for the
treatment of refractory hypertension. This approach bypasses the site of baroreceptor mechanosensory transduction. Chronic
electrical stimulation of arterial baroreceptors, particularly of the carotid sinus nerve (Hering’s nerve), was proposed as an
ultimate effort to treat refractory hypertension and angina pectoris due to the limited nature of pharmacological therapy available
at that time. Nevertheless, this approach was abandoned in the early 1970’s due to technical limitations of implantable devices
and to the development of better-tolerated antihypertensive medications. More recently, our laboratory developed the technique
of electrical stimulation of the aortic depressor nerve in conscious rats, enabling access to hemodynamic responses without the
undesirable effect of anesthesia. In addition, electrical stimulation of the aortic depressor nerve allows assessment of the
hemodynamic responses and the sympathovagal balance of the heart in hypertensive rats, which exhibit a well-known decrease
in baroreflex sensitivity, usually attributed to baroreceptor ending dysfunction. Recently, there has been renewed interest in
using electrical stimulation of the carotid sinus, but not the carotid sinus nerve, to lower blood pressure in conscious hypertensive
dogs as well as in hypertensive patients. Notably, previous undesirable technical outcomes associated with electrical stimulation
of the carotid sinus nerve observed in the 1960’s and 1970’s have been overcome. Furthermore, promising data have been
recently reported from clinical trials that evaluated the efficacy of carotid sinus stimulation in hypertensive patients with drug
resistant hypertension.
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Early studies of electrical stimulation of
baroreceptor afferents
Derangement of the carotid sinus as a possible cause
of the persistence of elevated blood pressure in hyperten-
sive animals was first suggested by McCubbin et al. (1) in
1956. Using an electroneurographic approach, the au-
thors demonstrated that in chronic renin-induced hyper-
tensive dogs there were fewer impulses along the carotid
sinus nerve than in the normotensive situation. The inves-
tigators hypothesized that there is an adaptation within the
baroreceptor end organ, which perpetuates, rather than
protects against, an elevation in blood pressure. However,
in 1958, Warner (2) demonstrated that activation of the
baroreflex by direct electrical stimulation of the carotid
sinus nerve (Hering’s nerve) reduced arterial pressure in
anesthetized normotensive dogs for periods lasting up to
90 min. Subsequent work showed that electrical stimula-
tion of the carotid sinus nerve for 10 to 20 s in patients
undergoing head and neck surgery elicited similar results,
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i.e., a rapid decrease in arterial pressure and heart rate
with return to baseline levels within seconds after ending
the stimulation (3). In 1964, Griffith and Schwartz (4) first
reported the reversal of arterial hypertension by electrical
stimulation of the carotid sinus nerve in anesthetized dogs.
These investigators demonstrated a sustained reduction
in systolic and diastolic pressure of approximately 60 mmHg
in renal hypertensive animals submitted to unilateral stim-
ulation of the carotid sinus nerve, with the opposite carotid
sinus nerve left intact, for periods of up to 90 min. When the
opposite nerve was transected, the animals responded
maximally to the electrical stimulus, indicating that the
opposite nerve, when left intact, buffered the hypotensive
response to electrical stimulation of its counterpart.
Subsequent studies provided similar results with pro-
longed electrical stimulation of the carotid sinus nerve in
dogs with chronic renal or acute neurogenic hypertension,
as well as in dogs with arteriosclerosis. This trend indicates
a return of arterial pressure to the prehypertensive control
levels and persistence of this reduced pressure throughout
the period of stimulation (5,6). Neistadt and Schwartz (6)
observed a significant reduction in arterial pressure to
electrical stimulation of the carotid sinus nerve in chronic
renal hypertensive dogs. This response was accompanied
by a reduction in cardiac output, with less reduction in renal
blood flow. The decrease in arterial pressure was main-
tained for periods of up to 6 h of stimulation, and the
response of the nerve to intermittent stimulation was effec-
tive 6 months after implantation of the stimulus device in
the carotid sinus nerve. Therefore, electrical stimulation of
baroreceptors was proposed as a supplementary treat-
ment for refractory hypertension due to the limitations of
pharmacological antihypertensive therapy available in the
early 1960’s (including undesirable side effects and lack of
responsiveness to available medication).
Studies in patients with refractory hypertension using
uni- or bilateral acute (3 min) and chronic (1 month to 2.5
years) electrical stimulation of the carotid sinus nerve
produced comparable results, i.e., reduction of systemic
arterial pressure and bradycardia (7-12). Bilgutay and
Lillehei (13) reported successful treatment of a patient
whose blood pressure was 260/165 mmHg despite the use
of four antihypertensive medications. After chronic bilat-
eral electrical stimulation of the carotid sinus, arterial pres-
sure was reduced to 150/90 mmHg and was maintained at
this level with continuation of baroreflex activation. In a
report of 8 patients with refractory hypertension, Schwartz
et al. (7) described a sustained reduction in blood pressure
of 48/42 mmHg with bilateral carotid nerve stimulation over
a period of 5 months to 2.5 years. Six patients were able to
discontinue antihypertensive medications and two others
required combined electrical stimulation of the carotid
sinus nerve and pharmacological antihypertensive medi-
cation to achieve a marked reduction in arterial pressure.
These studies revealed the efficacy of this technique to
chronically counteract a sustained increase in arterial pres-
sure by means of baroreflex activation.
In addition, electrical stimulation of the carotid sinus
nerve involving acute (20 s to 3 min) and chronic (1 to 24
months) stimulation regimens was used to reduce epi-
sodes of refractory angina pectoris in patients with coro-
nary artery disease, at rest and during exercise. Electrical
stimulation resulted in the reflex reduction of heart rate,
arterial pressure, myocardial contractility, tension time in-
dex, heart work, and myocardial oxygen demand (10,14-
17). In a study of 21 patients with intractable angina pecto-
ris, Braunwald et al. (14) demonstrated that activation of
the baroreflex caused a substantial improvement in symp-
toms, leading to better physical performance in 16 patients
during a period of 2 to 24 months postoperatively. Further-
more, electrical stimulation of the carotid sinus nerve was
also used to treat paroxysmal supraventricular tachycar-
dia refractory to the usual medications, which extremely
debilitated the patients (18). Thus, the efficacy of chronic
electrical activation of the baroreflex was extended be-
yond hypertensive states, improving the quality of life of
patients suffering from intractable angina pectoris.
Despite these encouraging findings from early clinical
studies, this approach was not pursued in the 1970s and
1980s owing to paramount limitations imposed by surgical
approaches and implantable devices. In most of the early
studies, the implantable device provided the current to
electrodes implanted around the carotid sinus nerve. This
protocol could damage the nerve during dissection and/or
electrode implantation. In addition, chronic carotid sinus
nerve stimulation itself could injure the nerve or promote
substantial fibrosis. Furthermore, the frequency and inten-
sity of stimulation required to achieve the desired hemody-
namic effects were not clear due to variability among
patients. When higher levels were required, stimulating
tissues adjacent to the carotid sinus nerve caused pain
and other painful symptoms. These symptoms included
dysphonia, dysphagia, coughing, gagging, hyperpnea, ta-
chypnea, dyspnea, hyperesthesias or paresthesias. In
addition, the implantable stimulating devices were very
bulky, battery capacity was sometimes insufficient and
some devices presented no external current control.
Despite development of a system that allowed
radiofrequency adjustment of the implanted devices and
permitted customization of treatment for each individual
(6,9,19), this approach to the treatment of hypertension
was abandoned, presumably due to the technological
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limitations mentioned above and to the development of
new antihypertensive drugs. However, the electrical stim-
ulation of baroreceptor afferents in anesthetized animals
has been continued as a useful tool to investigate the
reflex regulation of arterial pressure and heart rate in
several species, such as dogs, cats, rabbits, swine, and
rats (20-34).
Studies of baroreflex function by means
of electrical stimulation of baroreceptor
afferents
Electrical stimulation of baroreceptor afferents is a
technique widely used in several species for studies of
baroreflex control. In the rat, because the carotid sinus
nerve is very small, difficult to manipulate and has baro-
and chemoreceptor afferent fibers, the aortic depressor
nerve (ADN) has been more conspicuously studied. In
1963, Krieger and Marseillan (35) identified the routes
followed by the ADN fibers in the cervical region of anes-
thetized Wistar rats by means of electroneurographic re-
cording combined with electrical stimulation. Further stud-
ies demonstrated, by means of electrical stimulation, that
the Sprague-Dawley and Wistar rat ADN possessed al-
most exclusively baroreceptor afferent fibers and few, if
any, functional chemoreceptor afferent fibers (33,36). These
results established that electrical stimulation of the ADN in
rats is a reliable method for triggering baroreflex activation
in cardiovascular studies.
Electrical stimulation of the ADN or superior laryngeal
nerve in rats under different types of anesthesia (e.g.,
pentobarbital, α-chloralose or urethane) induced reflex
decreases in mean arterial pressure and heart rate that
were frequency-dependent (36-39). During graded electri-
cal activation of the ADN in rats, myelinated A fibers and
unmyelinated C fibers are recruited, producing maximal
decreases in mean arterial pressure at frequencies >10
Hz, and maximal bradycardia within 100-200 Hz (34,38,40).
Nevertheless, the activation of these two subtypes of baro-
receptor fibers appears to have distinct differences in
sensory function related to the regulation of systemic arte-
rial pressure and cardiac function. Activation of myelinated
A fibers in the ADN evoked reflex changes in mean arterial
pressure only at frequencies higher than 10 Hz, while
activation of unmyelinated C fibers acted at lower frequen-
cies, i.e., within 1-10 Hz. On the other hand, reflex control
of heart rate throughout selective A- and C-fiber activation
showed patterns of integration unexpectedly different from
those of the reflex control of mean arterial pressure. Selec-
tive stimulation of myelinated A fibers at high frequencies,
such as 200 Hz, was ineffective in producing bradycardia.
However, low frequencies, which activated unmyelinated
C fibers, produced substantial bradycardia, which became
maximal at activation rates =10 Hz, just as observed for
mean arterial pressure. Likewise, heart rate responses to
supramaximal activation of A and C fibers of the ADN have
an additive effect, whereas the hypotensive responses do
not (34,40).
Baroreceptor stimulation in anesthetized rats indicated
that electrical stimulation of the superior laryngeal nerve
evoked a pronounced reduction in hindquarter vascular
resistance. This type of stimulation produced a smaller, but
significant, reduction in mesenteric and renal vascular
resistance (37,39). On the other hand, Machado et al. (32)
demonstrated that electrical stimulation of the ADN pro-
duced an important reduction in hindquarter vascular re-
sistance with an increase in renal and mesenteric vascular
resistance, suggesting that the aortic baroreceptors play a
more important role in the regulation of blood flow in the
hindquarter than in the renal and mesenteric vascular
beds. In conscious rats, electrical stimulation of the ADN
by means of fixed frequency (50 Hz) and progressive
voltage (1 to 5 V) indicated that a decrease in mesenteric
resistance, in contrast to hindquarter resistance, did not
play a role in the hypotensive response (41). However,
electrical stimulation of the ADN with a fixed current (1 mA)
and progressive frequency (5 to 90 Hz) clearly demon-
strated that a conspicuous decrease in both mesenteric
and hindquarter resistance played a role in the hypoten-
sive response (42). Until now, the role played by changes
in vascular resistance in the hypotensive response during
carotid sinus stimulation in conscious dogs or humans has
not been reported.
Recently, Possas et al. (43) also demonstrated that
electrical stimulation of the ADN in pentobarbital-anesthe-
tized rats produced frequency-dependent decreases in
mean arterial pressure that were accompanied by pro-
nounced vasodilator responses in the hindquarter bed and
less pronounced vasodilator responses in the mesenteric
bed. According to these authors (43), this greater fall in
hindquarter resistance induced by electrical stimulation of
the ADN may involve the activation of postganglionic lum-
bar sympathetic vasodilator fibers, which release newly
synthesized and preformed nitrosyl factors.
Electrical stimulation of the ADN was also used to
examine the distribution of Fos protein-like immunoreac-
tivity in the rat brain in order to characterize the central
pathways involved in mediating the baroreceptor reflex
(44). This study found labeling in several discrete brain
nuclei, primarily on the ipsilateral side of stimulation. In the
medulla, labeled nuclei were found in the nucleus tractus
solitarii (NTS), area postrema, rostral and caudal ventro-
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lateral medulla, nucleus ambiguous and medullary reticu-
lar formation. Other areas in the pons and in the forebrain
were also labeled.
It is important to note that all previous studies that have
examined the responses to aortic baroreceptor stimulation
have been carried out in anesthetized rats, which may
have been subject to the influence of anesthesia on basal
parasympathetic and sympathetic tone, peripheral vascu-
lar resistance and central mediation of the baroreflex.
Thus, our laboratory developed (41) a technique to electri-
cally stimulate the ADN in conscious freely moving rats,
which allowed us to examine hemodynamic responses
such as reflex bradycardia, the fall in arterial pressure and
changes in regional vascular resistance (mesenteric, renal
and hindquarter) without the undesirable effects of anes-
thesia (41). In that study, electrical stimulation of the ADN
for 5 s in normotensive Wistar rats produced a fall in
pressure, bradycardia, and vasodilatation in the hindquar-
ter, but no change in mesenteric vascular resistance. It is
noteworthy that the progressive increase in randomly ap-
plied voltage elicited voltage-dependent reflex hypoten-
sion and bradycardia without causing any damage to ADN
afferents. This was demonstrated by the remarkable reflex
bradycardia caused by the increase in arterial pressure in
response to intravenous injection of phenylephrine at the
end of the set of electrical stimulation (Figure 1). In addi-
tion, the study demonstrated that methylatropine blocked
the reflex bradycardia almost completely without affecting
the degree of the hypotensive response. This finding indi-
cates that the decrease in heart rate played no significant
role in the reflex fall of arterial pressure, providing support
for a conspicuous role played by the decrease in peripher-
al vascular resistance elicited by the sympathoinhibition
during electrical stimulation of the ADN in conscious rats.
Furthermore, this technique also permitted research-
ers to investigate the role of different subtypes of ionotrop-
ic receptors in the NTS, N-methyl-D-aspartic acid (NMDA)
and non-NMDA receptors, which are activated by the
ubiquitous neurotransmitter L-glutamate, in the process-
ing of reflex bradycardia (parasympathoexcitation) and
hypotension (sympathoinhibition) (45). Inhibition of NMDA
and non-NMDA receptors in the commissural NTS by
microinjection of DL-2-amino-5-phosphonopentanoic acid
(AP-5, a selective NMDA receptor antagonist) and 6,7-
dinitroquinoxaline-2,3 dione (a selective non-NMDA re-
ceptor antagonist) produced complete blockade of the
reflex bradycardia in response to electrical stimulation of
the ADN, suggesting that the parasympathetic component
of the activation is mediated by both receptors. On the
other hand, the inhibition of NMDA and non-NMDA recep-
Figure 1. Electrical stimulation of the aortic depressor nerve in conscious normotensive rat. Typical tracings from conscious
normotensive Wistar rat showing the responses of heart rate (HR), pulsatile arterial pressure (PAP), and mean arterial pressure
(MAP) to electrical stimulation of the aortic depressor nerve, over a period of 5 s, with increasing voltage, and during intravenous
injection of phenylephrine (PHE). [Modified with permission from Am J Physiol Regul Integr Comp Physiol 1999; 277 (1 Part 2): R31-
R38].
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tors reduced the reflex hypotensive response by only
about 50%, suggesting that other metabotropic receptors,
or neurotransmitters other than L-glutamate, may play a
role in the neurotransmission of the sympathetic compo-
nent of the reflex arch.
Recently, we used electrical stimulation of the ADN in
conscious rats to investigate baroreflex function in normo-
tensive and hypertensive rats (42). Electrical stimulation of
the ADN for 5 s in conscious spontaneously hypertensive
rats (SHR) produced significant frequency-dependent de-
creases in arterial pressure and heart rate, as well as
decreases in hindquarter and mesenteric resistance (Fig-
ure 2). The absolute decrease in arterial pressure was
similar when normotensive rats were compared to SHR at
low frequencies. The decrease was significantly larger in
SHR at high frequencies of stimulation. Hindquarter va-
sodilatation in SHR was larger than mesenteric vasodila-
tion, while in normotensive rats the vasodilation exhibited
by these regions was equivalent. Heart rate responses did
not differ significantly between normotensive rats and SHR.
These findings demonstrate a well-preserved, or even
enhanced, baroreflex response in SHR that may reflect
diverse central baroreflex control in hypertensive and nor-
motensive rats. In addition, blockade of ß1-adrenergic
receptors with atenolol in normotensive rats did not affect
baroreflex-mediated decreases in mean arterial pressure
and heart rate elicited by electrical stimulation of the ADN.
However, atenolol significantly blunted baroreflex-medi-
ated bradycardia in SHR with no effect on baroreflex-
mediated decreases in mean arterial pressure. These
findings indicated that, in contrast to normotensive rats,
withdrawal of sympathetic activity contributed significantly
to baroreflex-mediated bradycardia in SHR. Thus, it can be
hypothesized that this observation is probably related to
the higher basal level of cardiac sympathetic tone in SHR.
In conscious chronically instrumented dogs, Lohmeier
et al. (46,47) observed that activation of the arterial barore-
flex for seven days by means of bilateral electrical stimula-
tion of the carotid sinus produced a remarkable and sus-
tained reduction in arterial pressure associated with mild
bradycardia. These changes were associated with a de-
crease of ~35% in plasma norepinephrine concentration,
indicating a conspicuous attenuation of the sympathetic
drive elicited by electrical stimulation of the carotid sinus.
Surprisingly, plasma renin levels did not change, as would
be expected due to the pronounced fall in arterial pressure,
suggesting that the baroreflex-mediated suppression of
renin activity may play a role in the sustained hypotensive
reflex response. After the discontinuation of baroreflex
activation, the hemodynamic responses and plasma lev-
Figure 2. Hemodynamic responses to electrical stimulation of the aortic depressor nerve in conscious rats. Typical tracings from
normotensive control rat (NCR) and spontaneously hypertensive rat (SHR) showing the responses of pulsatile arterial pressure (top),
heart rate (middle) and vascular resistance (hindquarter and mesenteric) (bottom) to electrical stimulation (ES, 30 Hz, 1 mA, 2 ms) of
the aortic depressor nerve over a period of 5 s. [Modified with permission from Am J Physiol Heart Circ Physiol 2007; 292 (1): H593-
H600].
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els of norepinephrine returned to basal levels.
Recent observations from the same group (48,49) pro-
vided similar results in conscious hypertensive dogs. Pro-
longed (seven-day) electrical activation of the carotid si-
nus decreased arterial pressure, attenuated the tachycar-
dia, and reduced plasma norepinephrine concentration in
dogs with obesity-induced hypertension (49). In contrast,
there were no changes in the hyperinsulinemia and hyper-
glycemia of obesity or plasma renin activity during pro-
longed baroreflex activation. These findings indicated that
baroreflex activation can chronically abolish sympathetic
activation associated with obesity, as well as the concur-
rent hypertension. Although electrical activation of the
baroreceptors reduced arterial pressure in conscious obese
hypertensive dogs, in conscious angiotensin II-infused
hypertensive dogs, this decrease in arterial pressure was
markedly attenuated (75 to 80%), in conjunction with a lack
of any significant change in heart rate. Therefore, Lohmeier
et al. (48) suggested that the activity of the renin-angio-
tensin-aldosterone system is a major determinant of the
arterial pressure-lowering effects of the baroreflex in differ-
ent forms of hypertension. They also asserted that angio-
tensin II probably acts in the central nervous system to
impair baroreflex control of renal sympathetic nerve activ-
ity and heart rate.
Moreover, the findings of Lohmeier et al. (48) strongly
suggest that the mechanism by which carotid sinus stimu-
lation reduces arterial pressure involves the attenuation of
the renal sympathetic tone; furthermore, pre-existing lev-
els of sympathetic activity probably affect this response.
However, this mechanism is not entirely straightforward; in
a recent study, Lohmeier et al. (50) demonstrated that after
renal denervation the hemodynamic and neuro-humoral
responses to electrical activation of the baroreflex were
similar to those observed before renal denervation. Thus,
the renal nerves are not necessary for achieving long-term
reductions in arterial pressure during prolonged electrical
baroreflex activation. Therefore, these recent findings not
only support the notion that the baroreflex plays a role in
long-term control of arterial pressure, but also encourage
novel studies utilizing prolonged activation of the carotid
sinus in hypertensive patients. This technique represents
a feasible, adjunct, non-pharmacological approach to the
treatment of hypertension.
Currently, electrical stimulation of the carotid sinus has
been reconsidered for use in hypertensive patients, since
the technical problems confronted in the early studies
seem to have been overcome with the use of modern
technologies involving electrodes and pulse-generating
devices. In addition, the technique used to place elec-
trodes has changed and nowadays the stimulating elec-
trodes are implanted around the carotid sinus rather than
around the carotid sinus nerve. This approach allows the
use of conventional techniques for electrode implantation
with a minimum probability of carotid sinus nerve damage,
commonly applied in the treatment of atherosclerotic dis-
ease of the carotid bifurcation.
Clinical studies using electrical stimulation of the ca-
rotid baroreceptors are already in progress, especially for
the treatment of patients with hypertension resistant to
pharmacological therapy (51-55). In the US, ten patients
with resistant hypertension after exposure to six antihyper-
tensive medications were submitted to chronic bilateral
electrical stimulation of the carotid sinus after successful
implantation of a new electronic device (51). This tech-
nique produced a remarkable acute voltage-dependent
decrease in systolic arterial pressure of 41 mmHg, in the
range of 0 to 6 V. The peak response was observed at 4.8
V and no significant bradycardia or detectable side effects
were detected during stimulation. Another study in eleven
patients undergoing elective surgery for carotid artery
disease demonstrated similar results during acute unilat-
eral electrical activation of the carotid sinus wall (53). A
voltage-dependent reduction in arterial pressure and heart
rate was observed, with a peak response at 4.4 V. In
addition, the authors demonstrated that the type of anes-
thesia used for the implantation of the electronic device
and the anatomy of the carotid sinus appear to affect the
hemodynamic response to baroreflex activation (53).
Tordoir et al. (54) reported the findings of the European
Multicenter Feasibility Study obtained from seventeen pa-
tients with drug-resistant hypertension. In that study, tests
performed during a period of 1 to 3 days postoperatively
resulted in a significant reduction in systolic and diastolic
arterial pressure and heart rate. Repeated testing during 3
months of electrical activation demonstrated a long-lasting
response and lower arterial pressure related to the thera-
peutic effects of electrical activation of the baroreflex.
As discussed above, these studies using acute or
prolonged stimulation of the carotid sinus have demon-
strated reductions in arterial pressure and heart rate after
triggering the baroreflex and, accordingly, increasing car-
diac parasympathetic activity and reduction of the sympa-
thetic drive. Thus, electrical stimulation of the carotid sinus
may represent a safe and effective therapeutic option for
the treatment of resistant hypertension. Moreover, as elec-
trical activation of the carotid baroreceptor reduces sym-
pathetic outflow, recent studies have also applied this
approach chronically to dogs (56). In dogs with chronic
heart failure submitted to carotid sinus stimulation, re-
searchers observed improved survival without enhanced
ventricular function, combined with suppression of plasma
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norepinephrine and plasma angiotensin II (56).
In conclusion, electrical activation of baroreceptor af-
ferents has proven to be a reliable approach to examine
baroreflex regulation in conscious normotensive and hy-
pertensive animals (rats and dogs). The technique has
been recently proposed and thoroughly tested, as an ad-
junct treatment of human refractory hypertension, cur-
rently representing a safe and effective therapeutic option.
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